Dr. Christopher J. McDougle, MD

Dr. McDougle practices at Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital.

Dr. McDougle's NPI, 1871547497, was assigned on May 19, 2006. Dr. McDougle graduated from Indiana University School of Medicine in 1986. Dr. McDougle holds Indiana license 01047650.

Dr. McDougle's primary practice is Boston Children's Hospital, at 300 Longwood Avenue, Boston, MA 02115 in Suffolk County. The practice phone is (617) 735-6000.

Dr. McDougle's primary practice is Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital. Dr. McDougle is also affiliated with Salem Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. McDougle to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDougle practices, 3 sites in all. Vendor and product names are available with a free account.

Child and adolescent psychiatry is Dr. McDougle's primary specialty in the NPI Registry, under taxonomy code 2084P0804X. Dr. McDougle is licensed in Indiana.

CMS data shows 82 Medicare services from Dr. McDougle across 2 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $7,780 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Dr. McDougle in 2024. 75% of them have anxiety, and 38% have mood disorders. Their average risk score is 0.69, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McDougle's median patient age at 23, with 27% women.

In 2024, Dr. McDougle wrote 1,305 Medicare Part D claims for 73 patients. 99% of them were for generic drugs. CMS names the drug for 1,217 of them, across 34 drugs with 11 or more claims each, at $37,645 in total drug cost. In 2023, CMS named 1,385 claims across 36 drugs.

Dr. McDougle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McDougle as offering telehealth.

Dmand AI links 153 papers to Dr. McDougle, published from 2010 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Autism Spectrum Disorder, Child Development Disorders, Pervasive and Autistic Disorder. Dr. McDougle has published most often in J Autism Dev Disord. Dr. McDougle's most frequent co-authors are Robyn Pauline Thom, MD, Craig A. Erickson, MD and Christopher J. Keary, MD.

Dmand AI links Dr. McDougle to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Asperger Syndrome, Child Development Disorders, Pervasive and Fragile X Syndrome.

CMS Open Payments shows 14 general payments to Dr. McDougle from 4 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $10,367.

Dr. McDougle graduated from Indiana University School of Medicine in 1986.